2026 data Public-data reference. official source

Stent, Renal

Open-data reference.

FDA MAUDE adverse event data · 2002–2026

What the Data Shows About Stent, Renal

The FDA MAUDE database aggregates 857 adverse-event reports for Stent, Renal spanning the period from 2002 through 2026. Of these, 32 are classified as death reports, 453 as injury reports, and 367 as malfunction reports under FDA adverse-event categorization rules. Report counts do not by themselves indicate a device is unsafe — widely used devices and longer market histories naturally generate larger raw counts, so proportional and comparative reads are more informative than totals alone.

The adverse-event profile breaks down across 5 distinct event types and 12 reported patient-outcome categories, giving a multi-dimensional view that goes beyond a single headline number. A total of 20 distinct product-problem codes appear in the reports, with Device Dislodged or Dislocated topping the list at 181 reports. Reports are associated with 10 different manufacturers in the MAUDE record, reflecting both OEMs and repackagers of this device category.

Annual reporting volume is tracked across 25 years of MAUDE data, with the peak single-year volume reaching 123 reports — trend shape often reflects changes in device adoption, reporting rules, or FDA enforcement focus rather than underlying device behavior alone. Events are documented across 6 reported care-setting categories (hospital, home, ambulatory surgery center, etc.). All figures reflect the openFDA MAUDE snapshot last refreshed on . This page is informational and is not medical advice — discuss device-safety questions with your healthcare provider.

857
Total Reports
32
Death Reports
453
Injury Reports
367
Malfunctions

Event Types

Injury 453 (52.9%)
Malfunction 367 (42.8%)
Death 32 (3.7%)
3 (0.4%)
Other 2 (0.2%)

Patient Outcomes

362 (39.1%)
Required Intervention 362 (39.1%)
Other 57 (6.2%)
R 42 (4.5%)
Hospitalization 35 (3.8%)
Death 33 (3.6%)
H 11 (1.2%)
S 7 (0.8%)
O 6 (0.6%)
Life Threatening 4 (0.4%)
L 3 (0.3%)
Disability 3 (0.3%)

Top Product Problems

Device Dislodged or Dislocated 181
Adverse Event Without Identified Device or Use Problem 84
Difficult to Remove 82
Failure to Advance 74
Difficult to Advance 48
Material Deformation 43
Improper or Incorrect Procedure or Method 42
Off-Label Use 31
Activation Failure 27
Leak/Splash 27
Material Rupture 24
Break 19
Material Separation 17
Premature Separation 16
Migration or Expulsion of Device 14
Migration 13
Inflation Problem 10
Unintended System Motion 10
Malposition of Device 9
Positioning Failure 8

Yearly Trend

02
2002: 1
03
2003: 7
04
2004: 13
05
2005: 18
06
2006: 11
07
2007: 8
08
2008: 10
09
2009: 11
10
2010: 4
11
2011: 21
12
2012: 38
13
2013: 45
14
2014: 28
15
2015: 70
16
2016: 34
17
2017: 61
18
2018: 123
19
2019: 62
20
2020: 55
21
2021: 47
22
2022: 39
23
2023: 47
24
2024: 53
25
2025: 42
26
2026: 9

Related Entities for Stent, Renal

Event Locations

414 (48.3%)
I 400 (46.7%)
HOSPITAL 34 (4.0%)
NO INFORMATION 6 (0.7%)
UNKNOWN 2 (0.2%)
OUTPATIENT TREATMENT FACILITY 1 (0.1%)

Compare AV-TEMECULA-CT vs ABBOTT VASCULAR →

Data Source

FDA Manufacturer and User Facility Device Experience (MAUDE) database via the openFDA API. Reports are submitted by manufacturers, healthcare facilities, and patients. Report counts do not indicate a device is unsafe — higher-use devices naturally generate more reports.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the FDA MAUDE database. Consult a qualified professional before making decisions based on this data.